Neuroimaging in neuro-oncology

SummaryNeuroimaging of brain tumors has evolved from a strictly morphology-based discipline to one that encompasses function, physiology, and anatomy. This review outlines the current imaging standard for patients with brain tumor and summarizes the latest advances in physiology-based imaging methods that complement traditional brain tumor imaging protocols. Emphasis is on the strength and limitations of the current imaging standards and on an overview of several advanced imaging methods including diffusion-weighted magnetic resonance imaging (MRI), perfusion MRI, and proton magnetic resonance spectroscopic (MRS) imaging. Basic physical principles behind each imaging method are briefly presented, along with a more in-depth discussion of clinical application and potential pitfalls of each technique.

[1]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[2]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[3]  Tracy T Batchelor,et al.  AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.

[4]  W P Dillon,et al.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.

[5]  Y. Zou,et al.  Diffusion tensor imaging of the brain in patients with Alzheimer’s disease and cerebrovascular lesions , 2007, Journal of Zhejiang University SCIENCE B.

[6]  Y Yonekura,et al.  Vascular permeability: quantitative measurement with double-echo dynamic MR imaging--theory and clinical application. , 2000, Radiology.

[7]  Kuni Ohtomo,et al.  Diffusion tensor tractography of gliomatosis cerebri: fiber tracking through the tumor. , 2005, Journal of computer assisted tomography.

[8]  P. Ricci Imaging of adult brain tumors. , 1999, Neuroimaging clinics of North America.

[9]  W. Dillon,et al.  Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. , 2002, Academic radiology.

[10]  Andrei I Holodny,et al.  Diffusion imaging in brain tumors. , 2002, Neuroimaging clinics of North America.

[11]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[12]  Susumu Mori,et al.  Diffusion tensor brain imaging and tractography. , 2002, Neuroimaging clinics of North America.

[13]  Peter Vajkoczy,et al.  Vascular microenvironment in gliomas. , 2004, Cancer treatment and research.

[14]  G. Johnson,et al.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. , 2001, AJNR. American journal of neuroradiology.

[15]  K. Plate,et al.  VEGF in Brain Tumors , 2000, Journal of Neuro-Oncology.

[16]  R. Henry,et al.  Diffusion Tensor MR Imaging and Fiber Tractography: Theoretic Underpinnings , 2008, American Journal of Neuroradiology.

[17]  S W Atlas,et al.  Subarachnoid space disease: diagnosis with fluid-attenuated inversion-recovery MR imaging and comparison with gadolinium-enhanced spin-echo MR imaging--blinded reader study. , 1998, Radiology.

[18]  T. Tali,et al.  Diagnostic value of contrast-enhanced fluid-attenuated inversion recovery MR imaging of intracranial metastases. , 2004, AJNR. American journal of neuroradiology.

[19]  Glyn Johnson,et al.  High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. , 2002, Radiology.

[20]  P. Burger,et al.  Histologic factors of prognostic significance in the glioblastoma multiforme , 1980, Cancer.

[21]  B. Rosen,et al.  Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd(DTPA) , 1992, Magnetic resonance in medicine.

[22]  Glyn Johnson,et al.  Measuring blood volume and vascular transfer constant from dynamic, T  2* ‐weighted contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.

[23]  A. Sorensen,et al.  Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. , 2002, AJR. American journal of roentgenology.

[24]  W P Dillon,et al.  Radiation injury of the brain. , 1991, AJNR. American journal of neuroradiology.

[25]  B. Drayer,et al.  Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? , 1998, AJNR. American journal of neuroradiology.

[26]  Richard A. Baum,et al.  Magnetic Resonance Angiography: Concepts and Applications , 1995 .

[27]  M. Castillo,et al.  Diffusion-weighted imaging in the evaluation of intracranial lesions. , 2000, Seminars in ultrasound, CT, and MR.

[28]  Glyn Johnson,et al.  Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. , 2003, AJNR. American journal of neuroradiology.

[29]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[30]  Ying Lu,et al.  Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients , 2002, Journal of magnetic resonance imaging : JMRI.

[31]  Christopher Nimsky,et al.  Visualization of the pyramidal tract in glioma surgery by integrating diffusion tensor imaging in functional neuronavigation. , 2005 .

[32]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[33]  G Johnson,et al.  Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2006, AJNR. American journal of neuroradiology.

[34]  B A Kall,et al.  Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. , 1987, Mayo Clinic proceedings.

[35]  P. Stewart,et al.  Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect. , 1987, Journal of neurosurgery.

[36]  D. Atkinson,et al.  Fluid-attenuated inversion recovery (FLAIR): clinical prospectus of current and future applications. , 1996, Topics in magnetic resonance imaging : TMRI.

[37]  Susan M. Chang,et al.  Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. , 2005, Journal of neurosurgery.

[38]  Douglas C. Miller,et al.  Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. , 2008, Radiology.

[39]  R R Edelman,et al.  Echo-planar MR imaging. , 1994, Radiology.

[40]  C. Claussen,et al.  Brain tumors: MR imaging with gadolinium-DTPA. , 1985, Radiology.

[41]  Elias R Melhem,et al.  Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[42]  F Ståhlberg,et al.  Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. , 2000, AJNR. American journal of neuroradiology.

[43]  J. Gillard,et al.  Diffusion-weighted MR Imaging of the brain , 2006 .

[44]  M Takahashi,et al.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.

[45]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[46]  P. Kleihues,et al.  Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors , 2000, Toxicologic pathology.

[47]  M Takahashi,et al.  Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. , 1999, Journal of computer assisted tomography.

[48]  L. D.,et al.  Brain tumors , 2005, Psychiatric Quarterly.

[49]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[50]  Elias R Melhem,et al.  Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience. , 2007, Radiology.